VIII因子遺伝子は,A型血友病のすべての症例を説明する
J A Naylor1, P M Green, C R Rizza
1Division of Medical & Molecular Genetics, United Medical School, Guy's Hospital, London, UK.
Lancet (London, England)
|October 31, 1992
まとめ
新しいmRNA分析により,重度のA型血友症において,以前に検出されなかったイントロン22変異が明らかになった. この発見は,重篤な疾患を引き起こすいくつかの因子VIII遺伝子変異が,以前に患者さんで見逃された理由を説明しています.
科学分野:
- 分子遺伝学 分子遺伝学
- 血液学 ヘマトロジ
- 遺伝子医学は遺伝医学である.
背景:
- 重度の血友病Aは,しばしば因子VIII遺伝子の変異によって引き起こされます.
- VIII因子遺伝子プロモーター,エクソン,イントロンの境界の標準的な遺伝分析では,重症疾患の原因となる変異の約50%を検出できていません.
- この診断のギャップの根本的な理由は不明のままである.
研究 の 目的:
- 重度のA型血友病における検出されていない変異の原因を調査する.
- 遺伝的発見と疾患の重症度の間の不一致を説明するために.
- 因子VIII遺伝子内の新規変異部位を特定する.
主な方法:
- ファクターVIII遺伝子変異を分析するためにmRNAベースの配列化アプローチを使用した.
- イントロン22の調査された領域は,以前は標準分析に含まれていなかった.
- 重度の影響を受けた患者からの臨床データと相関する遺伝的発見.
主要な成果:
- イントロン22のこれまで未調査の領域内の突然変異のクラスタを特定しました.
- これらの変異は,因子VIIImRNAのエクソン22と23の適切な結合を妨げます.
- これらのこれまで検出されなかった変異は,重症に罹患した24人中10人 (41.7%) の英国患者で発見されました.
結論:
- 因子VIII遺伝子のイントロン22の変異は,重度の血友病Aの重要な原因である.
- mRNAベースの方法は,従来の遺伝子検査で見逃された突然変異を成功裏に特定しました.
- この研究は,重度の血友病Aの診断のギャップの重要な理由を解明しています.
さらに関連する動画
07:15Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
03:45Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
関連する概念動画
Genetic Lingo
Overview
Multiple Allele Traits
The Concept of Multiple Allelism
Blood Types
Human blood is classified into different types based on the presence of antigens on the red blood cell's surface and antibodies in the plasma. Proper identification of blood type is essential for successful blood transfusion. The International Society of Blood Transfusion has identified 38 human blood types based on the surface antigens on the red blood cells. The most common types are ABO, Rh, and MNS blood types.
ABO blood group
ABO antigens are glycoproteins encoded by genes present on...
ABO blood group
ABO antigens are glycoproteins encoded by genes present on...
Blood Transfusion and Agglutination
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Factors Affecting Illness
When a person's physical, emotional, intellectual, social development or spiritual functioning is compromised, this deviation from a healthy normal state is called illness. Illness creates stress that in turn harms individuals. Irritation, anger, denial, hopelessness, and fear are behavioral and emotional changes an individual experiences in the phases of illness. A variety of factors influence a person's health and well-being.
For instance, risk factors are connected to illness, disability,...
For instance, risk factors are connected to illness, disability,...
Blood Typing
Understanding an individual's blood group is a critical component of transfusion medicine. It ensures compatibility in blood transfusions, organ transplants, and even during pregnancy. Determining these blood groups involves the ABO and Rh blood typing systems, utilizing specific antigens and corresponding anti-sera to identify an individual's blood type.
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target antigens A,...
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target antigens A,...
